Home  /  Resource Library  /  Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries

Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries

Study compared outcomes of CLL and follicular patients treated with Idelalisib in clinical trials versus the real world setting.